Related Experiment Video
Updated: Jun 17, 2025
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.9K
The Engineered Drug 3'UTRMYC1-18 Degrades the c-MYC-STAT5A/B-PD-L1 Complex In Vivo to Inhibit Metastatic
Chidiebere U Awah1,2, Joo Sun Mun3, Aloka Paragodaarachchi3,4
1Department of Biological Sciences, Hunter College, City University of New York, New York, NY 10065, USA.
Cancers
|August 10, 2024
Summary
Researchers developed a novel therapy targeting c-MYC overexpression in triple-negative breast cancer (TNBC). This approach destabilizes c-MYC mRNA, reducing tumor growth and improving survival in TNBC mouse models.
Area of Science:
- Oncology
- Molecular Biology
- Nanotechnology
Background:
- c-MYC is overexpressed in 70% of human cancers, including triple-negative breast cancer (TNBC).
- No current drugs directly target c-MYC.
- Targeting c-MYC is crucial for effective TNBC treatment.
Purpose of the Study:
- To engineer a novel therapeutic strategy to degrade c-MYC transcripts.
- To investigate the efficacy of MYC-destabilizing constructs in TNBC.
- To identify novel therapeutic targets in c-MYC-driven TNBC.
Main Methods:
- Engineering mRNA-stabilizing poly U sequences in the 3'UTR of c-MYC to promote transcript degradation.
- Complexing MYC-destabilizing constructs with iron oxide nanocages (IO-nanocages).
- Evaluating the therapeutic effect in mouse models of TNBC.
Main Results:
- Engineered constructs outcompeted endogenous c-MYC mRNA, reducing c-MYC levels.
- IO-nanocage complexes inhibited primary and metastatic tumors in TNBC mice.
- Treatment significantly prolonged survival by degrading c-MYC-STAT5A/B-PD-L1 complexes.
Conclusions:
- A novel therapy targeting c-MYC for TNBC has been developed.
- The c-MYC-STAT5A/B-PD-L1 interaction is a potential therapeutic target.
- This approach offers a new strategy for treating c-MYC-driven cancers.
Keywords:
c-MYC-STAT5A/5B-PD-L1 complexdestabilized 3′UTR (AU-rich elements)iron oxide nanocage (IO)mRNA poly U stabilizing elementsnonsense-mediated decay (NMD)triple-negative breast cancer (TNBC)More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.8K
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
13.1K
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:06Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K